Phosphodiesterase 5 Inhibitors: all 685 studies that test it

Page 7 of 7. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.

• Phase I Study to Investigate the Alcohol Interaction of SK3530CompletedNCT00489450Phase 1
• Hemodynamic Response After Six Months of SildenafilStatus unknownNCT00483626Phase 4
• Blood Pressure Interaction Between Sildenafil and Sublingual Glyceryl Trinitrate (GTN) in Men With AnginaCompletedNCT00479908Phase 4
• Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive BladderCompletedNCT00479505Phase 2
• The Pharmacological Basis for the Increase in Visual Time Constants Induced by Single Oral Doses of SildenafilStatus unknownNCT00463957Not applicable
• FDA Phase IV - Commitment - Retinal Function StudyCompletedNCT00461565Phase 4
• Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.CompletedNCT00457457Phase 2
• A Placebo-Controlled Single-Dose Trial of Sildenafil in SchizophreniaCompletedNCT00455715Phase 4
• Sildenafil (Viagra) Treatment of Subacute Ischemic StrokeTerminatedNCT00452582Phase 1
• Phase 1 Study of SK3530 to Investigate of the Effect of FoodCompletedNCT00443625Phase 1
• The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung DiseaseCompletedNCT00431418Phase 3
• Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile DysfunctionCompletedNCT00422578Phase 4
• Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord InjuryCompletedNCT00421083Phase 3
• Effect of Chronic PDE5-Inhibition on Endothelial Function in DiabeticsCompletedNCT00420901Phase 3
• Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract SymptomsCompletedNCT00408954Phase 2
• PDE5-Inhibition With Sildenafil in Chronic Heart FailureCompletedNCT00407446Phase 3
• A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mgCompletedNCT00382135Phase 4
• A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile DysfunctionCompletedNCT00381732Phase 3
• A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and DyslipidemiaCompletedNCT00379756Phase 4
• Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study IICompletedNCT00377793Phase 4
• Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in WomenCompletedNCT00375297Phase 4
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary HypertensionCompletedNCT00352482Phase 2
• Phase II Trial of SK3530 in Erectile DysfunctionTerminatedNCT00351065Phase 2
• Does Sildenafil Protect Against Pulmonary Related Complications Following Cardiopulmonary Bypass?Status unknownNCT00350441Phase 4
• Sulindac Capsules Compared With Sulindac Tablets in Healthy VolunteersCompletedNCT00343629Not applicable
• A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.CompletedNCT00343200Phase 4
• Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?CompletedNCT00334490Phase 2
• Efficacy and Safety of Tadalafil in Hemodialysis PatientsStatus unknownNCT00334477Phase 2
• A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six MonthsCompletedNCT00333281Phase 4
• Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous PolyposisStatus unknownNCT00319007Phase 2
• Effect of Regular Sildenafil on Blood Pressure and Arterial Function in HypertensionCompletedNCT00317421Phase 2
• Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning MalesStatus unknownNCT00313898Phase 4
• Study of Sildenafil in Patient With Heart Failure.CompletedNCT00309816Phase 3
• Study of Sildenafil in Advanced Heart Failure.CompletedNCT00309790Phase 3
• Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers SyndromeCompletedNCT00303004Phase 3
• Effect of Sildenafil on Endothelial FunctionStatus unknownNCT00297544Not applicable
• A Study of DA-8159 in Subjects With Erectile DysfunctionCompletedNCT00282607Phase 2
• A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral DosesCompletedNCT00273416Phase 2
• Healthy Volunteer Study of Sildenafil Effects Upon VisionCompletedNCT00251784Phase 4
• Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.CompletedNCT00249730Phase 4
• Evaluation of the Index of Sexual Life QuestionnaireCompletedNCT00245596Phase 4
• Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and SatisfactionCompletedNCT00245258Phase 4
• Sulindac in Preventing Breast Cancer in Women at High Risk for Breast CancerCompletedNCT00245024Phase 1
• Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
• Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?TerminatedNCT00215631Phase 3
• Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood VesselsCompletedNCT00199563Phase 4
• An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus)CompletedNCT00194909Phase 4
• Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type IIITerminatedNCT00194597Phase 4
• Interaction Between Fluvoxamine and SildenafilCompletedNCT00175981Phase 1
• Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile DysfunctionCompletedNCT00174486Phase 2
• Exisulind Versus Placebo After Surgical Removal of the ProstateCompletedNCT00166426Phase 2
• Sildenafil Citrate in Waldenstrom's MacroglobulinemiaCompletedNCT00165295Phase 2
• A Study of UK-369,003 on the Safety and Efficacy in Patients With COPDCompletedNCT00163098Phase 1/2
• Quality of Erection StudyCompletedNCT00159900Phase 4
• Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial HypertensionCompletedNCT00159887Phase 3
• Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile DysfunctionCompletedNCT00159809Phase 4
• Tadalafil in Subjects With Mild to Moderate HypertensionCompletedNCT00157326Phase 2
• Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary HypertensionWithdrawnNCT00155714Not applicable
• QEQ Treatment Responsiveness Evaluation StudyCompletedNCT00151463Phase 4
• To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .CompletedNCT00150358Phase 4
• Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject QuestionnaireCompletedNCT00147628Phase 4
• Sildenafil and Pulmonary Artery PressureTerminatedNCT00145938Phase 2
• Sildenafil For Meniere's DiseaseCompletedNCT00145483Phase 4
• Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-DoseCompletedNCT00143260Phase 4
• Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT00143221Phase 4
• Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile DysfunctionCompletedNCT00141349Phase 2
• Sildenafil Citrate for the Treatment of Established Pre-EclampsiaTerminatedNCT00141310Phase 2
• Mild To Moderate Erectile Dysfunction StudyCompletedNCT00137072Phase 4
• PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00125918Phase 3
• A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate CancerCompletedNCT00122499Phase 3
• A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsCompletedNCT00085826Phase 3
• Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate CancerCompletedNCT00080808Phase 2
• Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate CancerCompletedNCT00078910Phase 2
• Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT00072618Phase 1/2
• Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal CancerTerminatedNCT00062023Phase 2
• Sildenafil in Treating Erectile Dysfunction in Patients With Prostate CancerCompletedNCT00057759Not applicable
• Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell AnemiaCompletedNCT00056433Phase 1
• Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00052845Phase 2
• Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach EmptyingCompletedNCT00050609Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00041314Phase 2
• Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00041054Phase 2
• Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerCompletedNCT00039520Phase 2
• Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer PatientsCompletedNCT00037609Phase 1/2
• Exisulind in Preventing Polyps in Patients With Familial Adenomatous PolyposisWithdrawnNCT00026468Phase 2/3
• Sulindac and Plant Compounds in Preventing Colon CancerTerminatedNCT00003365Not applicable

← Phosphodiesterase 5 Inhibitors overview